Evidence map›Paper›PMID 39899442›Full record

ArticleCritical care explorations2025

The Maastricht Intensive Care COVID Cohort: A Critical Appraisal of the Predefined Research Questions.

Marieke S J N Wintjens, Eda Aydeniz, Frank van Rosmalen, Rob G H Driessen, Anne-Marije Hulshof, Dennis C J J Bergmans, Sander M J van Kuijk, Iwan C C van der Horst, Bas C T van Bussel, Maastricht Intensive Care COVID (MaastrICCht) collaborators

Abstract read
In one paragraph

Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marieke S J N WintjensDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Eda AydenizDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Frank van RosmalenDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Rob G H DriessenDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Anne-Marije HulshofCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Dennis C J J BergmansDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Sander M J van KuijkDepartment of Clinical Epidemiology and Technology Assessment, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Iwan C C van der HorstDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Bas C T van BusselDepartment of Intensive Care Medicine, Maastricht University Medical Centre +, Maastricht, The Netherlands.
Maastricht Intensive Care COVID (MaastrICCht) collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceA review of the study processes and protocols afterward by the researchers themselves is scarce.

objectivesThe present study aimed to evaluate the study design and the process of data collection of the Maastricht Intensive Care COVID (MaastrICCht) cohort during the COVID-19 pandemic. This evaluation provides information about the quality of the predefined questions and contributes to transparency in science. DESIGN, SETTING, AND

participantsCritical appraisal of studies using data from the MaastrICCht cohort. MAIN OUTCOMES AND MEASURES: Evaluation of the process of study design and data collection during the COVID-19 pandemic, focusing on the research process and results.

resultsFrom March 2020 to April 2023, all patients diagnosed with COVID-19 admitted to the ICU at Maastricht University Medical Center + (n = 544) were included in the MaastrICCht cohort. In total, 37 studies were carried out until April 2024. Fifteen studies addressed 11 of the 13 predetermined research questions, whereas 22 additional studies were performed based on the initial research questions described in the design. Furthermore, 10 studies were conducted with other researchers in national and international collaboration as a response to new arising questions based on evidence that appeared relevant during the pandemic. CONCLUSIONS AND RELEVANCE: Our critical appraisal indicated that using a study protocol enabled many publications and (inter)national collaborations, although formulating pertinent research questions in the context of a novel disease appeared daunting. Despite this, most questions were successfully addressed, whereas few were resolved by other researchers or lost importance due to the expanding body of knowledge.

Indexed as

COVID-19Critical CareIntensive Care UnitsResearch DesignCohort StudiesData CollectionHumansNetherlandsPandemicsSARS-CoV-2

Identifiers

PMID39899442
PMCPMC11793260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.